AI assistant
Sending…
LABCORP HOLDINGS INC. — Director's Dealing 2021
Jun 9, 2021
30237_dirs_2021-06-09_3f3e6214-2596-4002-a12e-0facaaa6e40a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2021-06-07
Reporting Person: van der Vaart Sandra D (EVP, Chief Legal Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-06-07 | Common Stock | M | 4500 | $84.86 | Acquired | 9737.0415 | Direct |
| 2021-06-07 | Common Stock | S | 4500 | $266.56 | Disposed | 5237.0415 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-06-07 | Non-qualified Stock Options | $84.86 | M | 4500 | Disposed | 2022-05-23 | Common Stock (4500) | Direct |
Footnotes
F1: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.
F2: Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2012 Omnibus Incentive Plan.
F3: The option vested in three equal annual installments beginning on the date reflected in this column and is now fully exercisable.
More from LABCORP HOLDINGS INC.
Regulatory Filings
2026
May 22
Interim / Quarterly Report
2026
May 4
Regulatory Filings
2026
Apr 30
Annual Report
2026
Apr 10
Proxy Solicitation & Information Statement
2026
Apr 10
Regulatory Filings
2026
Apr 9
Regulatory Filings
2026
Mar 31
Director's Dealing
2026
Mar 30
Director's Dealing
2026
Mar 30
Director's Dealing
2026
Mar 30